XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Cash flows from operating activities:              
Net loss $ (5,420) $ (2,424) $ (17,725) $ (6,270) $ (7,844) $ (23,997)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         12,328 14,349  
Impairment of fixed assets 0   1,243   0 1,243  
Postretirement Medical benefits gains         0 (14,577)  
Deferred income taxes         0 13,472  
Net gains from sales of assets         (4,429) (549)  
Net gains on derivative instruments         (7,952) (2,093)  
Other adjustments         2,808 1,776  
Change in operating assets and liabilities:              
Accounts receivable         (8,458) (818)  
Inventories         (11,634) (13,209)  
Derivative assets, net         8,201 1,761  
Other assets         2,273 2,418  
Accounts payable         8,237   $ 12,430
Accrued expenses and other         (2,125) 3,971  
Net cash used in operating activities         (8,595) (3,823)  
Cash flows from investing activities:              
Purchases of property, plant and equipment         (5,887) (9,636)  
Proceeds from sales of property, plant and equipment         8,175 1,926  
Net cash provided by (used in) investing activities         2,288 (7,710)  
Cash flows from financing activities:              
Proceeds from Credit Facilities         4,000 21,150  
Repayments on Credit Facilities         (4,000) (61,150)  
Payments of finance lease obligations         (23) (9)  
Payment of financing costs         (309) (2,614)  
Net cash used in financing activities         (332) (42,623)  
Net decrease in cash and cash equivalents and restricted cash         (6,639) (54,156)  
Cash and cash equivalents and restricted cash at beginning of period   $ 10,438   $ 60,013 10,438 60,013 $ 60,013
Cash and cash equivalents and restricted cash at end of period $ 3,799   $ 5,857   3,799 5,857  
Supplemental disclosure of non-cash investing and financing activities:              
Non-cash additions to property, plant and equipment         406 380  
Non-cash issuance of 401-K common stock         $ 134 185  
Cumulative preferred dividends, undeclared and unpaid           $ 284